NorthCrest Asset Manangement’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.59M Buy
92,073
+15,102
+20% +$1.22M 0.19% 119
2026
Q1
$6.67M Sell
76,971
-32,750
-30% -$3.14M 0.21% 115
2025
Q4
$10.7M Buy
109,721
+2,027
+2% +$197K 0.24% 101
2025
Q3
$10.6M Buy
107,694
+6,573
+7% +$604K 0.25% 96
2025
Q2
$8.94M Sell
101,121
-4,191
-4% -$355K 0.24% 103
2025
Q1
$9.46M Sell
105,312
-11,348
-10% -$1.02M 0.29% 94
2024
Q4
$9.32M Sell
116,660
-43
-0% -$3.72K 0.28% 96
2024
Q3
$10.5M Buy
116,703
+3,042
+3% +$256K 0.32% 88
2024
Q2
$8.95M Buy
113,661
+1,931
+2% +$158K 0.3% 93
2024
Q1
$9.74M Buy
111,730
+3,549
+3% +$303K 0.33% 93
2023
Q4
$8.91M Sell
108,181
-168,477
-61% -$12.8M 0.34% 89
2023
Q3
$21.7M Buy
276,658
+5,707
+2% +$478K 0.88% 25
2023
Q2
$23.9M Sell
270,951
-1,314
-0.5% -$113K 0.95% 22
2023
Q1
$22M Buy
272,265
+8,906
+3% +$726K 0.91% 26
2022
Q4
$20.5M Buy
263,359
+9,639
+4% +$781K 1.16% 16
2022
Q3
$20.5M Buy
253,720
+161,938
+176% +$14.6M 1.11% 14
2022
Q2
$8.24M Buy
91,782
+3,695
+4% +$374K 0.42% 87
2022
Q1
$9.77M Buy
88,087
+4,075
+5% +$431K 0.46% 81
2021
Q4
$8.69M Buy
+84,012
New +$9.73M 0.48% 69

Other funds holding MDT

NorthCrest Asset Manangement's MDT Position: Q2 2026 in Review

NorthCrest Asset Manangement increased its Medtronic (MDT) stake by 20% in Q2 2026, buying an estimated $1.22M and bringing the position to 92,073 shares worth $7.59M. The position accounts for 0.19% of the portfolio, ranked #119.

NorthCrest Asset Manangement first reported a position in MDT in Q4 2021 and has held it in 19 quarters since. The position peaked at $23.9M in Q2 2023. 353 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • NorthCrest Asset Manangement held 92,073 shares of Medtronic worth $7.59M as of Q2 2026.
  • NorthCrest Asset Manangement bought 15,102 Medtronic shares in Q2 2026, an estimated $1.22M.
  • Medtronic made up 0.19% of NorthCrest Asset Manangement's portfolio in Q2 2026, its #119 holding.
  • NorthCrest Asset Manangement first reported a position in Medtronic in Q4 2021 and has held it in 19 quarters since.
  • NorthCrest Asset Manangement's Medtronic position peaked at $23.9M in Q2 2023.
  • 353 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on NorthCrest Asset Manangement's 13F filing for Q2 2026, filed 15 Jul 2026.